Press releases

Seoul National University Hospital selects RayCare

RaySearch Laboratories AB (publ) announces that Seoul National University Hospital (SNUH) in South Korea has placed an order for the information oncology system RayCare®*. Recently, the hospital invested in RaySearch’s treatment planning system RayStation®*.

In April 2022 the carbon ion center at SNUH ordered RayStation treatment planning system, for use with their Toshiba Heavy Ion Therapy System. The hospital has now decided to invest in RayCare as their information oncology system.

Carbon ion therapy is a highly advanced radiation therapy technique that can be effective for complex tumors which are difficult to treat with conventional methods. SNUH is the second carbon ion center in Korea to select RaySearch with RayStation and RayCare, the first customer was Yonsei Cancer Center in Seoul.

Professor Hong-Gyun Wu, director, SNUH Gijang Cancer Center for Heavy Ion Therapy and Study, SNUH, says: “ With the introduction of software (RayStation, RayCare) from RaySearch, SNUH has taken a step further to open cancer center for heavy ion therapy and study. SNUH will take the lead in contributing to society by spurring research and development as well as treatment of cancer patients.”

Johan Löf, founder and CEO, RaySearch, says: “Recently SNUH decided to invest in our treatment planning system RayStation. Now I am happy to state that this prominent hospital has decided to also buy RayCare for their carbon ion center. With the additional order from SNUH RaySearch confirms our market leading position in this unique segment as well as acknowledges the fact that the number of new customers who choose RayCare as their oncology information system is increasing.”

About Seoul National University Hospital 
SNUH was founded in 1885 and for the past 130 years this national hospital has been leading the advancement of medicine in Korea. The SNU Cancer Hospital opened in March 2011 and consists of 28 specialized centers.

About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.  

RaySearch software is used by over 800 clinics in more than 40 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at

About RayStation
RayStation®* is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved.

About RayCare
The RayCare®* oncology information system (OIS) is designed to support the many complex logistical challenges faced by today’s oncology clinics. RayCare is closely integrated with RayStation®* and provides seamless access to all the powerful planning tools in RayStation and RayCommand®. The system efficiently coordinates activities in radiation therapy and offers advanced features for clinical workflow automation, and adaptive radiation therapy. RayCare responds to the demand from clinics for a more user-friendly and workflow-oriented information system that can support the cancer care of the future.

* Subject to regulatory clearance in some markets.

For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00

Björn Hårdemark, interim CFO, RaySearch Laboratories AB (publ) 
Telephone: +46 (0) 709 564 217